StockWatch
·
Pharmaceuticals
Board Meeting29 Oct 2026, 04:03 pm

Albert David Ltd Board Meeting on Nov 12 to Approve Q2 Results

AI Summary

Albert David Ltd has announced that its Board of Directors will convene on November 12, 2026, to consider and approve the unaudited financial results for the second quarter and half-year ended September 30, 2026. The trading window for the company's equity shares has been closed since October 1, 2026, and will reopen 48 hours after the results are declared. The company has also made this notice available on its website.

Key Highlights

  • Board meeting scheduled for November 12, 2026.
  • To approve unaudited financial results for Q2 and H1 FY27.
  • Trading window closed from October 1, 2026.
  • Results to be declared by November 12, 2026.
  • Notice available on company website.